Bruck Kifle

Array ( [id] => 5789704 [patent_doc_number] => 20020161248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Geminal-dinitro-1-5 diazocine derivatives' [patent_app_type] => new [patent_app_number] => 10/166278 [patent_app_country] => US [patent_app_date] => 2002-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6577 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20020161248.pdf [firstpage_image] =>[orig_patent_app_number] => 10166278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6413613 [patent_doc_number] => 20020183315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Amino-substituted compounds useful as inhibitors of impdh enzyme' [patent_app_type] => new [patent_app_number] => 10/155274 [patent_app_country] => US [patent_app_date] => 2002-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13315 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20020183315.pdf [firstpage_image] =>[orig_patent_app_number] => 10155274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6756507 [patent_doc_number] => 20030004284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Purification of N-vinyl-epsilon-caprolactam' [patent_app_type] => new [patent_app_number] => 10/152637 [patent_app_country] => US [patent_app_date] => 2002-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4237 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20030004284.pdf [firstpage_image] =>[orig_patent_app_number] => 10152637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1093193 [patent_doc_number] => 06825207 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-30 [patent_title] => 'Nitrogen-based camptothecin derivatives' [patent_app_type] => B2 [patent_app_number] => 10/154768 [patent_app_country] => US [patent_app_date] => 2002-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18753 [patent_no_of_claims] => 158 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 284 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/825/06825207.pdf [firstpage_image] =>[orig_patent_app_number] => 10154768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801639 [patent_doc_number] => 20030096804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Bicyclic inhibitors of factor Xa' [patent_app_type] => new [patent_app_number] => 10/153482 [patent_app_country] => US [patent_app_date] => 2002-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18152 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096804.pdf [firstpage_image] =>[orig_patent_app_number] => 10153482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1274570 [patent_doc_number] => 06649610 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-18 [patent_title] => '2-oxo-1, 4-benzoxazine compounds for treatment of tuberculosis' [patent_app_type] => B1 [patent_app_number] => 10/153111 [patent_app_country] => US [patent_app_date] => 2002-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 4329 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/649/06649610.pdf [firstpage_image] =>[orig_patent_app_number] => 10153111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721555 [patent_doc_number] => 20030055245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Kinetic resolution of a intermediate useful in the production of benazepril and analogues thereof' [patent_app_type] => new [patent_app_number] => 10/151772 [patent_app_country] => US [patent_app_date] => 2002-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3564 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055245.pdf [firstpage_image] =>[orig_patent_app_number] => 10151772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721351 [patent_doc_number] => 20030055041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Certain substituted caprolactam carbonates and ethers, pharmaceutical compositions containing them and their use in treating tumors' [patent_app_type] => new [patent_app_number] => 10/150778 [patent_app_country] => US [patent_app_date] => 2002-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11478 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055041.pdf [firstpage_image] =>[orig_patent_app_number] => 10150778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 941319 [patent_doc_number] => 06969710 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-29 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 10/144677 [patent_app_country] => US [patent_app_date] => 2002-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29568 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/969/06969710.pdf [firstpage_image] =>[orig_patent_app_number] => 10144677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1327929 [patent_doc_number] => 06599900 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-29 [patent_title] => '1-oxa-3,9-diaza-spiro5,5undecan-2-ones' [patent_app_type] => B2 [patent_app_number] => 10/143431 [patent_app_country] => US [patent_app_date] => 2002-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6876 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/599/06599900.pdf [firstpage_image] =>[orig_patent_app_number] => 10143431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6439716 [patent_doc_number] => 20020128257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Vitronectin receptor antagonist' [patent_app_type] => new [patent_app_number] => 10/141313 [patent_app_country] => US [patent_app_date] => 2002-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14022 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128257.pdf [firstpage_image] =>[orig_patent_app_number] => 10141313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6537366 [patent_doc_number] => 20020193364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => '1-azatricyclic-4-benzylpiperazines' [patent_app_type] => new [patent_app_number] => 10/140708 [patent_app_country] => US [patent_app_date] => 2002-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7194 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193364.pdf [firstpage_image] =>[orig_patent_app_number] => 10140708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1018033 [patent_doc_number] => 06890927 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-10 [patent_title] => 'Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof' [patent_app_type] => utility [patent_app_number] => 10/139730 [patent_app_country] => US [patent_app_date] => 2002-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 15968 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/890/06890927.pdf [firstpage_image] =>[orig_patent_app_number] => 10139730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1131096 [patent_doc_number] => 06787549 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-09-07 [patent_title] => 'Citrate salt of 5,8,14-triazatetracyclo10.3.1.02,11.04,9-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof' [patent_app_type] => B2 [patent_app_number] => 10/139449 [patent_app_country] => US [patent_app_date] => 2002-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9047 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/787/06787549.pdf [firstpage_image] =>[orig_patent_app_number] => 10139449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1248429 [patent_doc_number] => 06673786 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-06 [patent_title] => 'Tryptase inhibitors' [patent_app_type] => B1 [patent_app_number] => 10/049111 [patent_app_country] => US [patent_app_date] => 2002-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8933 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673786.pdf [firstpage_image] =>[orig_patent_app_number] => 10049111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7310533 [patent_doc_number] => 20040142919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Benzazepinone alpha vintegrin receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/475697 [patent_app_country] => US [patent_app_date] => 2003-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13410 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142919.pdf [firstpage_image] =>[orig_patent_app_number] => 10475697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1116049 [patent_doc_number] => 06800648 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-10-05 [patent_title] => 'Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-1,6,9-trioxa-3-AZA-cyclopentaanaphthalen-2-one' [patent_app_type] => B2 [patent_app_number] => 10/133994 [patent_app_country] => US [patent_app_date] => 2002-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7093 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 465 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/800/06800648.pdf [firstpage_image] =>[orig_patent_app_number] => 10133994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6537381 [patent_doc_number] => 20020193365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene as 5-HT1A antagonists' [patent_app_type] => new [patent_app_number] => 10/132237 [patent_app_country] => US [patent_app_date] => 2002-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8450 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193365.pdf [firstpage_image] =>[orig_patent_app_number] => 10132237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1096421 [patent_doc_number] => 06821981 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-23 [patent_title] => 'Azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino2,3-f-quinoline as 5-HT1A antagonists' [patent_app_type] => B2 [patent_app_number] => 10/131997 [patent_app_country] => US [patent_app_date] => 2002-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8954 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 307 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/821/06821981.pdf [firstpage_image] =>[orig_patent_app_number] => 10131997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6329865 [patent_doc_number] => 20020198217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Antipsychotic aminomethyl derivatives of 7,8-dihydro-2,6,9-trioxa-3-aza-cyclopenta[a]naphthalene' [patent_app_type] => new [patent_app_number] => 10/131343 [patent_app_country] => US [patent_app_date] => 2002-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7639 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20020198217.pdf [firstpage_image] =>[orig_patent_app_number] => 10131343 [rel_patent_id] =>[rel_patent_doc_number] =>)